The functions of the cdk-cyclin kinase inhibitor p21WAF1

J Boulaire1, A Fotedar, R Fotedar

  • 1Institut de biologie structurale J.P. Ebel, Grenoble, France.

Pathologie-Biologie
|June 20, 2000
PubMed

Insights

The protein p21WAF1 (p21) regulates cell growth and DNA damage response by inhibiting cell cycle progression and DNA synthesis. Its functions are crucial for cell cycle checkpoints and differentiation.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Genetics

Background:

  • p21WAF1 (p21) is a key regulator of cell cycle progression and DNA damage response.
  • p21 targets cyclin-dependent kinases (cdk-cyclins) and proliferating cell nuclear antigen (PCNA).
  • Distinct functional domains of p21 mediate inhibition of kinase activity and DNA synthesis.

Purpose of the Study:

  • To elucidate the critical roles of p21 in cell cycle regulation and DNA damage response.
  • To understand the molecular mechanisms by which p21 mediates cell cycle arrest.
  • To explore the transcriptional regulation of p21 beyond p53.

Main Methods:

  • Analysis of p21 interactions with cdk-cyclins and PCNA.
  • Investigation of p21's role in p53-mediated G-1 cell cycle arrest.
  • Examination of p21's contribution to G-2 arrest following DNA damage.

Main Results:

  • p21 inhibits cdk-cyclin kinase activity and PCNA-mediated DNA synthesis.
  • p53 upregulates p21 expression, which is essential for DNA damage-induced G-1 arrest.
  • p21 acts downstream of retinoblastoma protein in G-1 arrest and may contribute to G-2 arrest.

Conclusions:

  • p21 is a critical mediator of cell cycle checkpoints and DNA damage responses.
  • Transcriptional control of p21, independent of p53, is vital for growth arrest and differentiation.
  • p21's dual functions in inhibiting cell cycle progression and DNA synthesis highlight its importance in maintaining genomic stability.

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...